Approval · Notice of Compliance 5240 · 1995
SEVORANE: Notice of Compliance 5240
Issued September 18, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5240
- Date
- September 18, 1995
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Anaesthetic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SEVORANE | 02172763 | Marketed |
Medicinal ingredients
- SEVOFLURANE 99.97 PER